73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar
Scan based on lizard saliva detects rare tumor

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m
Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture
Cancer researchers find that tumors' metabolism is slower than suspected

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he
Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patientsby Julia Evangelou Strait,Washington University School of MedicineShown are multiple myeloma cells from a

Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patientsby Julia Evangelou Strait,Washington University School of MedicineShown are multiple myeloma cells from a
New therapeutic approach for the treatment of sarcoidosis

New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor

New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor
Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using
Scientists find dramatic rise in anal cancer in Midwest and Southeast

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m
HER2+ early breast cancers where shorter-course trastuzumab could be an option

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r